Association of the prostate cancer risk mutation G84E in HOXB13 with the subtype of ETS fusion negative adenocarcinoma with early age of diagnosis.
Thomas Schnoeller(Universität Ulm), Christiane Maier(University of Utah), Antje E. Rinckleb(Universität Ulm), Kathleen Herkommer(TUM Klinikum), Josef Hoegel(Universität Ulm), Zsofia Kote‐Jarai(Institute of Cancer Research), Janet L. Stanford, Manuel Luedeke(Universität Ulm), Hans Krause(Charité - Universitätsmedizin Berlin), Johanna Schleutker(University of Turku), Tiina Wahlfors, Liesel M. FitzGerald, Steffen Weikert(St. Hedwig-Krankenhaus), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust)
Cited by 0
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
The evolutionary history of lethal metastatic prostate cancer
|Nature|2015|1.4k
The Epidemiology of Renal Cell Carcinoma
|European Urology|2011|1k
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
|Nature Genetics|2018|1k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975